Literature DB >> 19525896

Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker?

Edward B Lee1, Tarik Tihan, Bernd W Scheithauer, Paul J Zhang, Nicholas K Gonatas.   

Abstract

Pituicytomas are rare low-grade gliomas of the neurohypophysis. Their morphology and variable immunophenotype have led to speculation that they arise from pituicytes. Given the role of thyroid transcription factor 1 (TTF-1) in the developing rodent infundibulum and its expression in the adult rat neurohypophysis, we speculated that TTF-1 would be a marker of human pituicytes. Using immunohistochemistry, we found that TTF-1 is strongly expressed in fetal and adult human pituicytes. A survey of sellar masses demonstrated specific TTF-1 expression in pituicytomas (n = 3), atypical pituicytomas (n = 2), and granular cell tumors (n = 4), indicating a common pituicyte lineage. TTF-1 expression in spindle cell oncocytomas (n = 8) is less easily explained but invites speculation. Our observations may have implications for the classification of these rare sellar neoplasms, all the while acknowledging the morphological diversity of pituicyte-related neoplasms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525896     DOI: 10.1097/NEN.0b013e3181a13fca

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  28 in total

Review 1.  Epithelioid pituicytoma.

Authors:  Jason A Ellis; Nadejda M Tsankova; Randy D'Amico; John C Ausiello; Peter Canoll; Marc K Rosenblum; Jeffrey N Bruce
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

Review 2.  Occult primary medullary thyroid carcinoma presenting with pituitary and parotid metastases: case report and review of the literature.

Authors:  Andrea Conway; Andres Wiernik; Ajay Rawal; Cornelius Lam; Hector Mesa
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

3.  TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma.

Authors:  Zaid Saeed Kamil; Grant Sinson; Hasan Gucer; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

4.  Freiburg Neuropathology Case Conference : A Pituitary Mass Lesion.

Authors:  C A Taschner; R Sankowski; J M Shah; H Urbach; R Hartmann; M Prinz
Journal:  Clin Neuroradiol       Date:  2016-12       Impact factor: 3.649

Review 5.  Spindle cell oncocytoma of the pituitary gland.

Authors:  Alexandra M Giantini Larsen; David J Cote; Hasan A Zaidi; Wenya Linda Bi; Paul J Schmitt; J Bryan Iorgulescu; Michael B Miller; Timothy R Smith; M Beatriz Lopes; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2018-10-19       Impact factor: 5.115

6.  Management of pituicytomas: a multicenter series of eight cases.

Authors:  Etienne Lefevre; Schahrazed Bouazza; Franck Bielle; Anne-Laure Boch
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

7.  Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells.

Authors:  Christian Hagel; Rolf Buslei; Michael Buchfelder; Rudolf Fahlbusch; Markus Bergmann; Armin Giese; Jörg Flitsch; Dieter K Lüdecke; Markus Glatzel; Wolfgang Saeger
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

8.  A history of pituitary pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

9.  Rare infundibular tumors: clinical presentation, imaging findings, and the role of endoscopic endonasal surgery in their management.

Authors:  Maria Koutourousiou; Paul A Gardner; Julia K Kofler; Juan C Fernandez-Miranda; Carl H Snyderman; L Dade Lunsford
Journal:  J Neurol Surg B Skull Base       Date:  2012-12-31

10.  Silent corticotroph adenoma with adrenal cortical choristoma: a rare but distinct morphological entity.

Authors:  Ozgur Mete; Thomas Ng; Darshika Christie-David; Jacqueline McMaster; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.